Posttranslational modifications in regulating Notch signaling pathway and tumor angiogenesis: from molecular mechanisms to therapeutic applications
Journal of Molecular Cell Biology · 2026
DOI: 10.1093/jmcb/mjaf051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Cell Biology, 2026. Verfasst von Jiaan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases & Department of Medical Genetics, Institute of Basic Medical Sciences & School o…. Hauptthemen laut MEDLINE: Signal Transduction, Neovascularization, Pathologic, Receptors, Notch, Protein Processing, Post-Translational. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumorigenesis exhibits complex interactions with the vascular system. Targeting angiogenesis represents an emerging strategy for remodeling the tumor microenvironment. The Notch signaling pathway, a key regulatory mechanism, orchestrates tumor angiogenesis by modulating endothelial cell differentiation and vascular homeostasis. However, the clinical translation of Notch-targeted therapies is limited by severe toxicities due to lack of tissue specificity. Posttranslational modifications (PTMs) chemically regulate protein functions, thereby influencing multiple signaling cascades, including Notch signaling. Notably, Notch-associated PTMs are essential for signal transduction integrity. Some types of PTMs, such as glycosylation and ubiquitination, are the core for maintaining the integrity of the Notch signaling pathway. Dysfunctional Notch-related PTMs disrupt signal fidelity and drive pathological angiogenesis. This review systematically explores (i) crosstalk between Notch signaling and tumor angiogenesis, (ii) regulatory roles of PTMs on Notch molecules in tumor angiogenesis, and (iii) therapeutic potential of targeting Notch-related PTMs for anti-angiogenic strategies in tumor. We aim to elucidate the molecular nexus of PTMs–Notch–angiogenesis in tumor progression. Furthermore, we discuss therapeutic challenges in modulating Notch signaling pathway-dependent PTMs within tumor angiogenesis, focusing on critical barriers to their clinical translation in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Common Mechanism Research for Major Diseases & Department of Medical Genetics, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union M…
ORCID-Profile: Donglai Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Zhang, M., & Wang, D. (2026). Posttranslational modifications in regulating Notch signaling pathway and tumor angiogenesis: from molecular mechanisms to therapeutic applications. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjaf051
Vancouver
Wang J, Zhang M, Wang D. Posttranslational modifications in regulating Notch signaling pathway and tumor angiogenesis: from molecular mechanisms to therapeutic applications. Journal of Molecular Cell Biology. 2026. doi:10.1093/jmcb/mjaf051
BibTeX
@article{Wang2026,
author = {Wang, Jiaan and Zhang, Meng and Wang, Donglai},
title = {Posttranslational modifications in regulating Notch signaling pathway and tumor angiogenesis: from molecular mechanisms to therapeutic applications},
journal = {Journal of Molecular Cell Biology},
year = {2026},
doi = {10.1093/jmcb/mjaf051}
}
EUVIMED